According to UroGen Pharma's latest financial reports the company's current EPS (TTM) is -โน398.76. In 2022 the company made an earnings per share (EPS) of -โน407.28 an increase over its 2021 EPS that were of -โน422.62.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน384.30 | -5.64% |
2022 | -โน407.28 | -3.63% |
2021 | -โน422.62 | -16.22% |
2020 | -โน504.41 | 15.63% |
2019 | -โน436.25 | 7.56% |
2018 | -โน405.58 | 160.58% |
2017 | -โน155.64 |